04-06-2026 08:10 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Aurobindo Pharma Ltd.
Change Company   
BSE Code 524804
ISIN Demat INE406A01037
Book Value 394.82
NSE Code AUROPHARMA
Dividend Yield % 0.28
Market Cap 828716.78
P/E 34.32
EPS 41.97
Face Value 1  
03-Jun-2026 Aurobindo Pharma informs about analyst meet
25-May-2026 Aurobindo Pharma’s arm’s Telangana facility class...
22-May-2026 Aurobindo Pharma reports marginal rise in Q4 cons...
22-May-2026 Aurobindo Pharma’s arm incorporates wholly owned ...
16-May-2026 Aurobindo Pharma’s arm gets CDSCO’s marketing aut...
16-May-2026 Aurobindo Pharma informs about updates
15-May-2026 Announcement under Regulation 30 (LODR)-Closure ...
06-May-2026 Aurobindo Pharma gets EIR for Telangana unit
06-May-2026 Aurobindo Pharma informs about updates
06-May-2026 Aurobindo Pharma zooms after getting EIR for Tela...
02-May-2026 Aurobindo Pharma’s arm gets Health Canada’s nod f...
21-Apr-2026 Letter Of Offer For Buyback Of Up To 54,23,728 ...
18-Apr-2026 Aurobindo gets nod for Dextromethorphan Polistire...
17-Apr-2026 Aurobindo Pharma gets USFDA’s final nod for Glyce...
17-Apr-2026 Aurobindo Pharma informs about press release
Page 1 of 4
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.